Pooled Analysis of Aids-Malignancy Consortium (AMC) Trials Evaluating Rituximab Plus either CHOP or Infusional EPOCH Chemotherapy in HIV-Associated Non-Hodgkin Lymphoma

BACKGROUND: Improved outcomes have recently been reported for rituximab (R) plus infusional EPOCH chemotherapy in HIV-associated, aggressive B-cell non-Hodgkin’s lymphoma (NHL). The objective of this analysis was to assess whether patient selection or other factors contributed to this improvement an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Barta, Stefan K, Lee, Jeannette Y, Kaplan, Lawrence D, Noy, Ariela, Sparano, Joseph A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3310940/
https://ncbi.nlm.nih.gov/pubmed/22180164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26723
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak